Objective Peripheral arterial disease (PAD) afflicts up to 20% of older people and is
associated with a high risk of cardiovascular (CV) morbidity, but a rather low risk of …

Background—The 1-year restenosis rate after balloon angioplasty of long lesions in below-
the-knee arteries may be as high as 70%. Our aim was to investigate the efficacy of a …

BACKGROUND: The goal of this study was to review the currently available literature and to
compare the short and long-term results of primary stenting and angioplasty of …

Objectives: The aim of this study was to assess the safety and effectiveness of directional
atherectomy (DA) for endovascular treatment of peripheral arterial disease (PAD) in …

Objectives: This study sought to compare paclitaxel-eluting balloon (PEB) with conventional
percutaneous transluminal angioplasty (PTA), followed by systematic implantation of a self …

Objectives The purpose of the DEFINITIVE Ca++ study was to evaluate the safety and
effectiveness of directional atherectomy and distal embolic protection, used together to treat …

BACKGROUND: Despite the recent development of endovascular therapy (EVT), a high
incidence of restenosis remains as an unsolved issue in patients presenting with …

Cilostazol is a unique antiplatelet agent that has been commercially available for over two
decades. As a phosphodiesterase III inhibitor, it reversibly inhibits platelet aggregation yet …

Background Cystathionine γ‐lyase, cystathionine β‐synthase, and 3‐mercaptopyruvate
sulfurtransferase are endogenous enzymatic sources of hydrogen sulfide (H2S). Functions …

The failure of endovascular treatments of peripheral arterial disease represents a critical
clinical issue. Specialized data are required to tailor such procedures to account for the …